Wednesday, July 8, 2026
🇺🇸 FDA

biotech · Colorectal Cancer · Psoriatic Arthritis, Rheumatoid Arthritis · CRDF

Cardiff Oncology

Cardiff Oncology trial registry — 60 ClinicalTrials.gov studies with program phase, status, and indication context.

Website Investor relations
11055 Flintkote Avenue, San Diego, California 92121, US HQ
1999 Founded
51 Employees
Public company Type
CRDF · NYSE Ticker
Company details
Status
Public
HQ
11055 Flintkote Avenue, San Diego, California 92121, US
Founded
1999
Employees
51
Programs
58
Drugs
62
Patents
69
Official website ↗ All projects Drug pipeline Patents News & analysis

Recent coverage

View all news & analysis →
Intelligence · Clinical Trials

Cardiff Oncology clinical trials

Registry index of 60 ClinicalTrials.gov studies linked to Cardiff Oncology programs — each row shows trial ID, program name, phase, status, and indication.

Cardiff Oncology trial registry — 60 ClinicalTrials.gov studies with program phase, status, and indication context.

Recent trial activity

8 updates

Latest clinical program signals indexed for Cardiff Oncology.

  1. SPON - 1751-19 — Phase 2

    Clinical update

  2. CISPLATIN, CARBOPLATIN — Phase 3

    Clinical update

  3. Tyenne 162 mg solution for injection in pre-filled pen — Phase 2

    Clinical update

  4. Tyenne 162 mg solution for injection in pre-filled pen — Phase 2

    Clinical update

  5. KEYTRUDA 25 mg/mL concentrate for solution for infusion — Phase 2

    Clinical update

  6. Pro insulin peptide — Phase 2

    Clinical update

  7. Ponatinib — Phase 2

    Clinical update

  8. Oral triiodothyronine — Phase 3

    Clinical update

Trial registry

60 studies

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.